Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means
- 2 December 2021
- journal article
- research article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (7) , 4912-4922
Abstract
Background Pancreaticoduodenectomy (PD) remains the cornerstone of managing pancreatic ductal adenocarcinoma (PDAC) of the pancreas head/neck, but it is associated with high morbidity. We hypothesize that, in absence of pancreatectomy-specific morbidity (PSM), minimally invasive PD (MIPD) provides improved short-term outcomes compared to open PD (OPD). Methods NSQIP pancreatectomy-targeted database 2014–2019 was utilized. PSM was defined as the occurrence of delayed gastric emptying (DGE) and/or post-operative pancreatic fistula (POPF). The cohort was divided into No-PSM and PSM groups. Propensity score match was applied in each group to compare outcomes of MIPD vs. OPD. Results 8,121 patients were selected. Patients were divided into No-PSM (N = 6267) and PSM (N = 1854) groups. In No-PSM group, we matched 1656 OPD to 552 MIPD patients. MIPD had longer operations (423 vs. 359 min; p < 0.001) but less overall morbidity (22.1% vs. 29.1%; p = 0.001) mostly attributed to less bleeding and sepsis. MIPD patients also had a one-day shorter median LOS (6 vs. 7 days; p = 0.005) and higher rates of home discharge (92.8% vs. 89.6%; p = 0.027). No difference was noted in mortality and 30-day readmission. In PSM group, 441 OPD were matched to 147 MIPD peers. MIPD had longer operations but without short-term benefits. General morbidity (61.2% vs. 61.9%), median LOS (12 vs. 12 days), mortality (2.7% vs. 1.8%), and readmission rates (32.7% vs. 26.5%) were similar. Same conclusions were drawn in the per-protocol analysis. Conclusion PSM is common following PD for PDAC. In the absence of PSM, MIPD is associated with less postoperative morbidity and shorter LOS.Keywords
This publication has 30 references indexed in Scilit:
- Does Minimally-Invasive Pancreaticoduodenectomy Have Advantages over Its Open Method? A Meta-Analysis of Retrospective StudiesPLOS ONE, 2014
- Return to intended oncologic treatment (RIOT): A novel metric for evaluating the quality of oncosurgical therapy for malignancyJournal of Surgical Oncology, 2014
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- 250 Robotic Pancreatic ResectionsAnnals of Surgery, 2013
- Assessing the impact of a fistula after a pancreaticoduodenectomy using the Post‐operative Morbidity IndexHPB, 2013
- Time to Initiation of Postoperative ChemotherapyDiseases of the Colon & Rectum, 2013
- Robotic versus Open Pancreatectomy: A Systematic Review and Meta-analysisAnnals of Surgical Oncology, 2013
- Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinomaJournal of Surgical Oncology, 2012
- A Margin-Negative R0 Resection Accomplished With Minimal Postoperative Complications Is the Surgeon's Contribution to Long-Term Survival in Pancreatic CancerJournal of Gastrointestinal Surgery, 2006
- Laparoscopic pylorus-preserving pancreatoduodenectomySurgical Endoscopy, 1994